<?xml version="1.0" encoding="UTF-8"?>
<p id="Par17">Pathologically, all patients with locally advanced gastric cancer received postoperative adjuvant chemotherapy (a 3 week cycle SOX regime). S-1, 40-60 mg (40 mg when BSA &lt; 1.25 m
 <sup>2</sup>, 60 mg when BSA &gt; 1.5 m
 <sup>2</sup>), twice per day, Day 1–14; Oxaliplatin (130 mg/m
 <sup>2</sup>) was given intravenously at the first day of each cycle. Toxicity of the regime was graded based on the Common Terminology Criteria for Adverse Events version 4.0.
</p>
